Company: GCL
Filing Date: 2025-08-27
Form Type: DRS
Source: 0001213900-25-080905
Chunk: 295

Company: GCL Global Holdings Ltd
Filing Date: 2025-08-27
Form: DRS
Chunk 295
---
4 |             |   |     | 2023 |             |
|:-------------------------------------------------------|:----|:------------------------------|------------:|:----|:-----|------------:|:--|:----|:-----|------------:|
| Net income (loss) attributable to the Company’s        
 shareholders                                           |     | $                             |   5,587,625 |     | $    |  (1,373,504 | ) |     | $    |   1,986,119 |
| Denominator:                                           |     |                               |             |     |      |             |   |     |      |             |
| Weighted average number of ordinary shares outstanding |     |                               | 107,184,280 |     |      | 105,013,283 |   |     |      | 104,972,026 |
| Earning (loss) per ordinary share – basic and diluted  |     | $                             |        0.05 |     | $    |       (0.01 | ) |     | $    |        0.02 |

The following ordinary shares equivalents were
excluded from the computation to eliminate any antidilutive effect:

|                                      |     | As of     
 March 31, 
 2025      |            |     | As of     
 March 31, 
 2024      |   |     | As of     
 March 31, 
 2023      |   |
|:-------------------------------------|:----|:----------|-----------:|:----|:----------|:--|:----|:----------|:--|
| Warrant (1)                          |     |           | 16,500,000 |     |           | - |     |           | - |
| Ordinary shares placed in escrow (2) |     |           |  4,328,394 |     |           | - |     |           | - |

| (1) | For the years ended March 31, 2025, 2024, and 2023, the Company had                                          
 the 16,500,000, 0, and 0 shares of warrants, respectively, outstanding which were not included in the        
 calculation of diluted net (income) loss per ordinary share because inclusion thereof would be anti-dilutive |

| (2) | For the years ended March 31, 2025, 2024, and 2023, the Company had                                    
 4,328